Rapid progression of prostate cancer in men with a BRCA2 mutation.
about
Brca2 and Trp53 deficiency cooperate in the progression of mouse prostate tumourigenesisGermline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer.Cancer biomarker discovery: the entropic hallmark.Personalized prostate cancer screening among men with high risk genetic predisposition- study protocol for a prospective cohort study.Direct cooperation between androgen receptor and E2F1 reveals a common regulation mechanism for androgen-responsive genes in prostate cells.Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis.Differing clinical impact of BRCA1 and BRCA2 mutations in serous ovarian cancer.Skp2 overexpression is associated with loss of BRCA2 protein in human prostate cancer.The therapeutic ratio is preserved for radiotherapy or cisplatin treatment in BRCA2-mutated prostate cancersCancer worry among Norwegian male BRCA1/2 mutation carriers.BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients.The role of BRCA1 and BRCA2 mutations in prostate, pancreatic and stomach cancersInterest of individuals from BRCA families to participate in research studies focused on male BRCA carriersAn inherited NBN mutation is associated with poor prognosis prostate cancerDetermining the frequency of pathogenic germline variants from exome sequencing in patients with castrate-resistant prostate cancer.Genetic evaluation and testing for hereditary forms of cancer in the era of next-generation sequencing.Biallelic BRCA2 Mutations Shape the Somatic Mutational Landscape of Aggressive Prostate TumorsA personalised approach to prostate cancer screening based on genotyping of risk founder allelesGermline BRCA mutations denote a clinicopathologic subset of prostate cancer.The role of BRCA1 and BRCA2 in prostate cancer.Germline genetic profiling in prostate cancer: latest developments and potential clinical applications.Familial prostate cancer: the damage done and lessons learnt.New insights into the prevention and treatment of familial breast cancer.BRCA1 and BRCA2 - update and implications on the genetics of breast cancer: a clinical perspective.The genetic epidemiology of prostate cancer and its clinical implications.An arranged marriage for precision medicine: hypoxia and genomic assays in localized prostate cancer radiotherapy.Nucleic acid-based tissue biomarkers of urologic malignancies.Hereditary breast cancer syndromes and genetic testing.Investigating BRCA Mutations: A Breakthrough in Precision Medicine of Castration-Resistant Prostate Cancer.PTEN deletion in prostate cancer cells does not associate with loss of RAD51 function: implications for radiotherapy and chemotherapy.The presence of prostate cancer at biopsy is predicted by a number of genetic variants.The impact of a BRCA2 mutation on mortality from screen-detected prostate cancer.Urologists' and GPs' knowledge of hereditary prostate cancer is suboptimal for prostate cancer counseling: a nation-wide survey in The Netherlands.Sustained Complete Response to Cytotoxic Therapy and the PARP Inhibitor Veliparib in Metastatic Castration-Resistant Prostate Cancer - A Case Report.Update on Screening for Urological Malignancies.Genetic variants associated with predisposition to prostate cancer and potential clinical implications.NSGC practice guideline: risk assessment and genetic counseling for hereditary breast and ovarian cancer.Germline BRCA mutation in male carriers-ripe for precision oncology?Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study.Within-Gender Differences in Medical Decision Making Among Male Carriers of the BRCA Genetic Mutation for Hereditary Breast Cancer.
P2860
Q27347240-B2EB2AAF-C3FF-48C2-ACF0-4C6727ED69D4Q27852185-FD268463-D8D4-474F-990F-1660B42BCE08Q30496149-37F632D4-7A0D-4190-9108-AECB97FE6526Q30597063-D4EB2310-87B2-4570-95FA-88B96EA8103FQ33636324-4C6A1C1E-6C2E-4FAB-904F-69FC6EADC754Q34168304-A06DB7D6-A5B1-4AC4-BA18-C0ED78DC3E42Q34305493-27688D67-E15F-4E00-8232-831ED2919174Q34838226-382E6551-F34B-4AF2-B51D-4209247B313CQ35014762-450D7EA1-B296-4D1A-960F-A49FB78C132AQ35219186-1667D81C-C04B-4A6A-A5B4-0B50A774FD7DQ35527158-0BA123E6-F7DC-4FFB-981C-5F263D9CF147Q35906685-7FAC7567-8D94-4E29-A0DB-2CAA9987A9BBQ35907075-5262C5EE-7012-4050-8B79-F29B8C9E8E97Q36594121-0C8ACC3C-D944-4A6A-ACFF-8A879725A118Q36818918-93952A41-7FA3-458B-B808-9F0978F7A89DQ36849670-198E5A34-3CCA-478E-B258-273E40923827Q36891144-6A38D46F-09AF-451B-8A08-DBD2DDF08C46Q36959139-85A10F7D-B6D1-4B38-8D3A-093341A931B5Q37019841-2F2177C5-446B-47BA-91F2-2B140B8A6A79Q37037789-FE0C03E4-688E-4C96-9487-DBDC1E78B081Q37474516-EC2B00DA-58E0-492D-8DAB-CE7E849F3498Q37553869-852675A0-1A93-4520-829A-682BCF189C2DQ37845305-DFF47A62-7729-49DD-B57B-87C6B33A45FDQ38151730-0190C5C4-53A0-4D62-8B9E-52ADC44B4D3AQ38168060-C5A4800F-8E77-4C1F-A355-B3D32A65D0E9Q38192714-42F13ABF-336F-4391-99A8-A53610B3FF39Q38216131-66E74016-3A52-4E83-A966-F077BDF186A7Q38266306-2AB02159-CC0F-42F1-8347-7697EBB468F7Q38893354-318ECBE4-A4D9-44C2-980F-8FD751AF1AC1Q39437808-43BB92EA-8C17-4501-95DF-F5BB50624DCCQ40137412-05EA2258-6036-4A06-8496-A2ADD7FF5CBBQ40213120-B95814E3-7CFF-46B1-A6BD-125C39200365Q42182516-239067C8-BD26-40A8-986A-0F70B3F6460DQ42370398-F271BAA6-F422-4388-947D-D86B1399D1E7Q42649779-1151B01A-7DCC-4D55-A7C5-5244287DBCEAQ43415543-7254806B-F264-4636-B0F0-9254C8E5FF12Q46782906-D1DF19A4-AD6A-4A55-BB09-29D87B74CE4EQ46798905-42842A6B-26CF-46AE-96ED-B57C8E373DCBQ46935108-3DF2DA2A-720A-4769-AE14-E3BE6BE3B6B9Q47138471-493F1AAE-A7B4-434B-AE2B-FA40AFB8F344
P2860
Rapid progression of prostate cancer in men with a BRCA2 mutation.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Rapid progression of prostate cancer in men with a BRCA2 mutation.
@en
type
label
Rapid progression of prostate cancer in men with a BRCA2 mutation.
@en
prefLabel
Rapid progression of prostate cancer in men with a BRCA2 mutation.
@en
P2093
P2860
P50
P356
P1476
Rapid progression of prostate cancer in men with a BRCA2 mutation.
@en
P2093
Andrea Eisen
Barbara Pasini
Beth Karlan
Charmaine Kim-Sing
Christina Bellati
Christine Maugard
Dawna Gilchrist
Douglas Horsman
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604453
P407
P50
P577
2008-06-24T00:00:00Z